Try our Advanced Search for more refined results
Dolin v. Smithkline Beecham Corporation, et al
Case Number:
1:12-cv-06403
Court:
Nature of Suit:
365(Personal Inj. Prod. Liability)
Judge:
Firms
- Dentons
- Husch Blackwell
- King & Spalding
- Perl & Goodsnyder
- Phillips Lytle
- Pietragallo Gordon
- Rapoport Law Offices
- Swanson Martin
- The Horwitz Law Group
- Troutman Pepper
- Wiedner & McAuliffe
- Williams & Connolly
- Wisner Baum
Companies
Sectors & Industries:
-
November 17, 2016
GSK Defends Suicide Expert In Trial Over Reed Smith Death
GlaxoSmithKline told an Illinois federal judge Wednesday that his doubts about an expert witness are unfounded, defending its decision to call a non-doctor in an upcoming trial over a Reed Smith LLP partner's suicide.
-
October 18, 2016
GSK Can't Seek To Deflect Blame, Reed Smith Widow Says
GlaxoSmithKline PLC shouldn't be allowed to argue at trial that anyone other than the company itself bears responsibility for its drugs labeling, the widow of a Reed Smith LLP partner who killed himself after taking the company's antidepressant told an Illinois federal judge Monday.
-
September 23, 2016
GSK Still Wants Hearing On Expert Of Reed Smith Atty's Widow
GlaxoSmithKline PLC on Thursday urged an Illinois federal court not to call off a pretrial hearing to vet the mental health expert of a widow of a Reed Smith LLP partner who killed himself after taking the company's antidepressant, saying it is making a legitimate request for information.
-
August 02, 2016
No Need For Hearing Vetting Suicide Expert, Atty's Widow Says
The widow of a Reed Smith LLP partner who killed himself after taking a GlaxoSmithKline PLC antidepressant urged an Illinois federal court Monday to cancel a pretrial hearing to vet her mental health expert, saying an investigation into the death of one of his patients found no wrongdoing.
-
May 23, 2016
Reed Smith Widow Says Expert Was Cleared In Patient Suicide
The widow of a Reed Smith LLP partner who killed himself in 2010 after taking a generic version of GlaxoSmithKline's antidepressant Paxil told an Illinois federal court on Friday that a British medical authority cleared her expert witness, a psychiatrist, of malpractice over a separate suicide of a patient.
-
March 15, 2016
GSK Can't Get Docs On Expert For Reed Smith Atty's Widow
GlaxoSmithKline PLC was dealt a setback Tuesday when an Illinois federal judge declined to grant its bid for documents relating to the doctor serving as an expert witness for the widow of a Reed Smith LLP partner who committed suicide in 2010 after taking a generic version of GSK's antidepressant Paxil.
-
February 19, 2016
GSK Ruling Raises Bar For Pharma On Brand Label Warnings
An Illinois federal court's finding that GlaxoSmithKline PLC didn't show that federal regulators would have rejected a warning that its antidepressant Paxil could make adult patients suicidal sets a high bar of proof for branded-drug makers under evidence standards outlined by the Supreme Court's landmark Wyeth ruling, attorneys say.
-
February 11, 2016
GSK Gets Quick No To Request To Duck Reed Smith Case
An Illinois federal judge granted GlaxoSmithKline's demand for a prompt decision by ruling against the company Thursday, rejecting two motions to end claims by the widow of a Reed Smith LLP partner that the drugmaker concealed data linking its antidepressant Paxil to suicide.
-
February 04, 2016
Judge In Reed Smith Suicide Case Can't Beeline To Trial: GSK
GlaxoSmithKline PLC told an Illinois federal judge Thursday he can't just skip ahead to trial in a suit by the widow of a Reed Smith LLP partner accusing the drugmaker of concealing data linking its drug Paxil to suicide, urging him to first rule on its pending motions to end the suit.
-
January 12, 2016
Reed Smith Atty's Widow, GSK Headed To Trial In Suicide Suit
In a rare move Tuesday, an Illinois federal judge ruled that a suit filed by the widow of a Reed Smith LLP partner accusing GlaxoSmithKline PLC of concealing data linking its drug Paxil to suicide should move straight to trial, bypassing motions filed by the drugmaker.